Premium
HIV/SARS‐CoV‐2 coinfected patients in Istanbul, Turkey
Author(s) -
Altuntas Aydin Ozlem,
Kumbasar Karaosmanoglu Hayat,
Kart Yasar Kadriye
Publication year - 2020
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.25955
Subject(s) - coinfection , virology , covid-19 , human immunodeficiency virus (hiv) , antibody , medicine , viral load , immunology , outbreak , infectious disease (medical specialty) , disease
HighlightsCOVID‐19 coinfection has improved in HIV‐infected cases that use regular ART and where viral load is suppressed, and even in advanced HIV‐infected cases without treatment. Although the data are not yet sufficient, the impression is that the presence of comorbidities is an important factor in mortality in HIV/SARS‐CoV‐2 coinfected cases. Radiological imaging findings were observed in all HIV‐infected cases, even in the case with very low CD4 cell count. And, with immunochromatographic antibody tests, it was observed that antibody formation time was similar to uninfected individuals.